1. Home
  2. BCRX vs NGVT Comparison

BCRX vs NGVT Comparison

Compare BCRX & NGVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCRX
  • NGVT
  • Stock Information
  • Founded
  • BCRX 1986
  • NGVT 1964
  • Country
  • BCRX United States
  • NGVT United States
  • Employees
  • BCRX N/A
  • NGVT N/A
  • Industry
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • NGVT Major Chemicals
  • Sector
  • BCRX Health Care
  • NGVT Industrials
  • Exchange
  • BCRX Nasdaq
  • NGVT Nasdaq
  • Market Cap
  • BCRX 1.8B
  • NGVT 2.0B
  • IPO Year
  • BCRX 1994
  • NGVT N/A
  • Fundamental
  • Price
  • BCRX $8.27
  • NGVT $59.77
  • Analyst Decision
  • BCRX Strong Buy
  • NGVT Buy
  • Analyst Count
  • BCRX 10
  • NGVT 2
  • Target Price
  • BCRX $16.70
  • NGVT $58.00
  • AVG Volume (30 Days)
  • BCRX 2.3M
  • NGVT 289.1K
  • Earning Date
  • BCRX 11-03-2025
  • NGVT 10-28-2025
  • Dividend Yield
  • BCRX N/A
  • NGVT N/A
  • EPS Growth
  • BCRX N/A
  • NGVT N/A
  • EPS
  • BCRX N/A
  • NGVT N/A
  • Revenue
  • BCRX $557,506,000.00
  • NGVT $1,324,800,000.00
  • Revenue This Year
  • BCRX $41.37
  • NGVT N/A
  • Revenue Next Year
  • BCRX $7.56
  • NGVT $5.18
  • P/E Ratio
  • BCRX N/A
  • NGVT N/A
  • Revenue Growth
  • BCRX 45.85
  • NGVT N/A
  • 52 Week Low
  • BCRX $6.02
  • NGVT $28.49
  • 52 Week High
  • BCRX $11.31
  • NGVT $59.95
  • Technical
  • Relative Strength Index (RSI)
  • BCRX 43.55
  • NGVT 73.79
  • Support Level
  • BCRX $8.02
  • NGVT $57.20
  • Resistance Level
  • BCRX $8.68
  • NGVT $57.92
  • Average True Range (ATR)
  • BCRX 0.22
  • NGVT 1.39
  • MACD
  • BCRX 0.01
  • NGVT 0.01
  • Stochastic Oscillator
  • BCRX 37.88
  • NGVT 97.79

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

Share on Social Networks: